Johnson & Johnson continues to leverage its expertise in Innovative Medicine and MedTech

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are personal
Johnson & Johnson continues to leverage its expertise in Innovative Medicine and MedTech

Katelyn Forde, a Pharmaceutical Biotechnology student from Munster Technological University, was presented with a bespoke framed glass artwork to mark her receipt of a scholarship from global healthcare company, Johnson & Johnson, as part of its WiSTEM2D Programme. 

At Johnson & Johnson, we believe health is everything. 

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. 

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Johnson & Johnson has a long heritage in Ireland since 1935, and a large footprint with a workforce of more than 6,000 people.

Its Irish operations which comprise both the Innovative Medicine and MedTech segments, make a significant contribution to the company’s global success with ten sites located in five counties (Cork, Dublin, Limerick, Galway and Mayo) spanning research and development, manufacturing, shared services and country commercial businesses. 

Veronica Howells, a Chemistry of Pharmaceutical Compounds student from University College Cork, was presented with a bespoke framed glass artwork to mark her receipt of a scholarship from global healthcare company, Johnson & Johnson, as part of its WiSTEM2D Programme. The WiSTEM2D Programme showcases Johnson & Johnson’s commitment to developing and implementing high-impact strategies to support female students undertaking STEM2D degree courses in universities around the world.
Veronica Howells, a Chemistry of Pharmaceutical Compounds student from University College Cork, was presented with a bespoke framed glass artwork to mark her receipt of a scholarship from global healthcare company, Johnson & Johnson, as part of its WiSTEM2D Programme. The WiSTEM2D Programme showcases Johnson & Johnson’s commitment to developing and implementing high-impact strategies to support female students undertaking STEM2D degree courses in universities around the world.

In 2024, Johnson & Johnson underwent a rebrand in Ireland, and each of the business segments adopted the Johnson & Johnson brand name. This builds on the Company’s legacy, while also modernising key elements to showcase healthcare innovation in a way that is inclusive and demonstrates the Company’s ability to tackle the world’s toughest health challenges.

Johnson & Johnson leverages its expertise in innovative medicine and medical technology to prevent and treat complex diseases and introduce solutions that are smarter, less invasive, and more personalised. Johnson & Johnson innovates with purpose to improve patient outcomes and make a lasting impact on healthcare in Ireland.

In November 2024, Johnson & Johnson announced the recipients of its prestigious Women in STEM²D (WiSTEM²D) Undergraduate Awards at its national event held in Thomond Park Stadium, Limerick.

The Award recognises outstanding female students in STEM²D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design.

82 students from Trinity College Dublin, University of Limerick, University College Cork, University of Galway, Munster Technology University, Atlantic Technological University and Maynooth University have received awards as part of the programme. 

This marks a 33% increase in recipients compared to 2023, highlighting the programme’s growing impact and recognition of talented female students in STEM²D fields.

 To learn more about Johnson & Johnson’s WiSTEM²D programme, visit www.jnj.com/wistem2d . Learn more about Johnson & Johnson at www.jnj.com/ .

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited